Related Experiment Video
Updated: Jun 21, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Intensive insulin therapy and insulin pumps
1Diabetes Resource Center, Piedmont Hospital in Atlanta, GA, USA. BBODE001@aol.com
Transitioning to intensive insulin therapy for diabetes mellitus requires a well-designed program. Personalized insulin regimens and delivery systems enhance patient motivation and long-term success.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacology
Background:
- Intensive insulin therapy is crucial for managing diabetes mellitus.
- Patient transition to new therapy regimens can be challenging.
- Motivation and information are key for successful treatment adherence.
Purpose of the Study:
- To outline strategies for a smoother transition to intensive insulin therapy.
- To emphasize the importance of patient-centered treatment planning.
- To improve long-term outcomes for patients with diabetes mellitus.
Main Methods:
- Review of current best practices in diabetes management.
- Analysis of factors influencing patient adherence to insulin therapy.
- Emphasis on individualized treatment selection.
Main Results:
- A structured treatment program enhances patient motivation and understanding.
- Tailoring insulin regimens and delivery systems to individual needs facilitates adaptation.
- Proactive patient education and support are critical.
Conclusions:
- Carefully designed programs are essential for successful intensive insulin therapy adoption.
- Personalized approaches improve patient transition and adherence.
- Optimizing insulin therapy selection leads to better long-term diabetes management.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
